Fiche centre
Altoona Center for Clinical Research
Duncansville — United States
Essais liés3clinical trials
VilleDuncansvillelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03742037
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System | SEP | Non applicable | NCT03437473 | Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | COMPLETED |
| SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System | SEP | Non applicable | NCT04862117 | Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | ACTIVE_NOT_RECRUITING |
| Cenerimod 0.5 mg | Lupus | Phase 2 | NCT03742037 | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus | COMPLETED |